Christopher Loose

2019

In 2019, Christopher Loose earned a total compensation of $2.9M as Chief Scientific Officer at Korro Bio, a 401% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$230,000
Option Awards$2,278,077
Salary$379,167
Other$7,271
Total$2,894,515

Loose received $2.3M in option awards, accounting for 79% of the total pay in 2019.

Loose also received $230K in non-equity incentive plan, $379.2K in salary and $7.3K in other compensation.

Rankings

In 2019, Christopher Loose's compensation ranked 4,235th out of 13,971 executives tracked by ExecPay. In other words, Loose earned more than 69.7% of executives.

ClassificationRankingPercentile
All
4,235
out of 13,971
70th
Division
Manufacturing
1,548
out of 5,701
73rd
Major group
Chemicals And Allied Products
542
out of 2,200
75th
Industry group
Drugs
454
out of 1,886
76th
Industry
Pharmaceutical Preparations
348
out of 1,398
75th
Source: SEC filing on April 29, 2020.

Loose's colleagues

We found two more compensation records of executives who worked with Christopher Loose at Korro Bio in 2019.

2019

David Lucchino

Korro Bio

Chief Executive Officer

2019

Carl LeBel

Korro Bio

Chief Development Officer

News

In-depth

You may also like